A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population

被引:237
作者
Staehling-Hampton, K
Proll, S
Paeper, BW
Zhao, L
Charmley, P
Brown, A
Gardner, JC
Galas, D
Schatzman, RC
Beighton, P
Papapoulos, S
Hamersma, H
Brunkow, ME
机构
[1] Celltech R&D Inc, Bothell, WA 98021 USA
[2] Univ Cape Town, Sch Med, Dept Human Genet, ZA-7700 Rondebosch, South Africa
[3] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 110卷 / 02期
关键词
endosteal hyperostoses; sclerosteosis; chromosomal deletion; van Buchem disease; SOST/AF326739; MEOX1/U10492;
D O I
10.1002/ajmg.10401
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Van Buchem disease is an autosomal recessive sclerosing bone dysplasia characterized by skeletal hyperostosis, overgrowth of the mandible, and a liability to entrapment of the seventh and eighth cranial nerves. The genetic determinant maps to chromosome 17q12-q21. We refined the critical interval to the < 1-Mb region between D17S2250 and D17S2253 in 15 affected individuals, all of whom shared a common disease haplotype. Furthermore, we report here the identification of a 52-kb deletion located within the interval and encompassing D17S1789 that is 100% concordant with the disorder. Although the deletion itself does not appear to disrupt the coding region of any known or novel gene(s), the closest flanking genes are MEOX1 on the proximal side, and SOST on the distal side of the deletion. MEOX1 is known to be important for the development of the axial skeleton, whereas the SOST gene is the determinant of sclerosteosis, a disorder that shares many features with van Buchem disease, thus raising the possibility that van Buchem disease results from dysregulation of the expression of one or both of these genes. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:144 / 152
页数:9
相关论文
共 40 条
[1]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[2]  
ALVES AFD, 1982, REV BRAS GENET, V5, P825
[3]   Localization of the gene for sclerosteosis to the van Buchem Disease-gene region on chromosome 17q12-q21 [J].
Balemans, W ;
Van Den Ende, J ;
Paes-Alves, AF ;
Dikkers, FG ;
Willems, PJ ;
Vanhoenacker, F ;
de Almeida-Melo, N ;
Alves, CF ;
Stratakis, CA ;
Hill, SC ;
Van Hul, W .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (06) :1661-1669
[4]   Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) [J].
Balemans, W ;
Ebeling, M ;
Patel, N ;
Van Hul, E ;
Olson, P ;
Dioszegi, M ;
Lacza, C ;
Wuyts, W ;
Van den Ende, J ;
Willems, P ;
Paes-Alves, AF ;
Hill, S ;
Bueno, M ;
Ramos, FJ ;
Tacconi, P ;
Dikkers, FG ;
Stratakis, C ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :537-543
[5]   CLINICAL FEATURES OF SCLEROSTEOSIS - REVIEW OF MANIFESTATIONS IN 25 AFFECTED INDIVIDUALS [J].
BEIGHTON, P ;
DURR, L ;
HAMERSMA, H .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (04) :393-397
[6]   SYNDROME OF THE MONTH - SCLEROSTEOSIS [J].
BEIGHTON, P .
JOURNAL OF MEDICAL GENETICS, 1988, 25 (03) :200-203
[7]  
BEIGHTON P, 1979, S AFR MED J, V55, P783
[8]  
BEIGHTON P, 1984, CLIN GENET, V25, P175
[9]   CONSTRUCTION OF A TRANSCRIPTION MAP SURROUNDING THE BRCA1 LOCUS OF HUMAN-CHROMOSOME-17 [J].
BRODY, LC ;
ABEL, KJ ;
CASTILLA, LH ;
COUCH, FJ ;
MCKINLEY, DR ;
YIN, GY ;
HO, PP ;
MERAJVER, S ;
CHANDRASEKHARAPPA, SC ;
XU, JZ ;
COLE, JL ;
STRUEWING, JP ;
VALDES, JM ;
COLLINS, FS ;
WEBER, BL .
GENOMICS, 1995, 25 (01) :238-247
[10]   Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein [J].
Brunkow, ME ;
Gardner, JC ;
Van Ness, J ;
Paeper, BW ;
Kovacevich, BR ;
Proll, S ;
Skonier, JE ;
Zhao, L ;
Sabo, PJ ;
Fu, YH ;
Alisch, RS ;
Gillett, L ;
Colbert, T ;
Tacconi, P ;
Galas, D ;
Hamersma, H ;
Beighton, P ;
Mulligan, JT .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) :577-589